dr. Bram De Laere
- ORCID iD
- 0000-0002-1174-0384
Show
Sort by
-
Androgen deprivation therapy in advanced prostate cancer : insights from a real-world patient survey on health-related quality of life and information and communication sources
-
Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping
-
Genomic determinants of patterns of failure in metachronous oligometastatic castration-sensitive prostate cancer
-
Overcoming complex polyclonality for accurate clinical genotyping in metastatic prostate cancer
-
- Journal Article
- A1
- open access
AR and PI3K genomic profiling of cell-free DNA can identify poor responders to Lutetium-177-PSMA among patients with metastatic castration-resistant prostate cancer
-
WNT pathway mutations in metachronous oligometastatic castration-sensitive prostate cancer
-
Multi-focal genomic dissection of synchronous primary and metastatic tissue from de novo metastatic prostate cancer
-
Clinical trial protocol for ProBio : an outcome-adaptive and randomised multiarm biomarker-driven study in patients with metastatic prostate cancer
-
Towards the discovery of prognostic and predictive biomarkers in CHEERS, a radioimmunotherapy phase II trial
-
Toward methodology for comprehensive androgen receptor splice variant profiling in cell-free RNA from patients with metastatic prostate cancer